You-Bin Lee Selected Research

LDL Cholesterol

1/2023	Association between lipid variability and the risk of mortality in cancer patients not receiving lipid-lowering agents.
11/2022	Association between cholesterol levels and dementia risk according to the presence of diabetes and statin use: a nationwide cohort study.
1/2022	Myocardial Infarction, Stroke, and All-Cause Mortality according to Low-Density Lipoprotein Cholesterol Level in the Elderly, a Nationwide Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

You-Bin Lee Research Topics

Disease

11	Type 2 Diabetes Mellitus (MODY) 05/2024 - 01/2017
8	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 09/2018
6	Diabetes Mellitus 01/2023 - 01/2016
5	Myocardial Infarction 01/2024 - 09/2021
5	Obesity 01/2022 - 01/2017
5	Insulin Resistance 11/2021 - 01/2016
4	Neoplasms (Cancer) 01/2024 - 04/2021
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 01/2019
4	Stroke (Strokes) 01/2022 - 09/2021
4	Non-alcoholic Fatty Liver Disease 07/2021 - 01/2020
3	Diabetes Complications 01/2021 - 10/2017
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2018 - 01/2016
2	Body Weight (Weight, Body) 05/2024 - 11/2021
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2024 - 01/2021
2	Hyperaldosteronism (Conn Syndrome) 12/2023 - 12/2022
2	Overweight 01/2023 - 11/2021
2	Dementia (Dementias) 11/2022 - 10/2020
2	Heart Failure 10/2022 - 01/2020
2	Hypoglycemia (Reactive Hypoglycemia) 10/2022 - 11/2019
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2020 - 09/2018
1	Ganglioneuroma 02/2024
1	Pituitary Neoplasms (Pituitary Adenoma) 02/2024
1	Mental Disorders (Mental Disorder) 01/2024
1	Psychotic Disorders (Schizoaffective Disorder) 01/2024
1	Ischemic Stroke 01/2024
1	Adenoma (Adenomas) 12/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Osteoporosis 08/2022
1	Spondylolisthesis 08/2022
1	Metabolic Bone Diseases (Osteopenia) 08/2022
1	Left Ventricular Dysfunction 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Thyroid Neoplasms (Thyroid Cancer) 11/2021
1	Paraganglioma (Paragangliomas) 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Pheochromocytoma 01/2021
1	Atherosclerosis 10/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2020
1	Hepatoblastoma 09/2020
1	Fatty Liver 09/2020
1	Glucose Intolerance 09/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Metabolic Diseases (Metabolic Disease) 11/2019
1	Neointima 11/2019
1	Atrial Fibrillation 01/2019
1	Prediabetic State (Prediabetes) 01/2017
1	Wernicke Encephalopathy (Wernicke's Encephalopathy) 04/2016
1	Crohn Disease (Crohn's Disease) 04/2016

Drug/Important Bio-Agent (IBA)

18	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2016
7	Insulin (Novolin)FDA Link 01/2023 - 09/2020
4	oxidized low density lipoproteinIBA 01/2024 - 09/2018
4	CholesterolIBA 01/2024 - 01/2019
4	Indicators and Reagents (Reagents)IBA 10/2020 - 10/2017
3	LipidsIBA 01/2023 - 09/2020
3	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2021
3	LDL CholesterolIBA 01/2023 - 01/2022
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2022 - 09/2021
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 11/2019
2	Antidepressive Agents (Antidepressants)IBA 02/2024 - 01/2023
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 02/2024 - 11/2021
2	AldosteroneIBA 12/2023 - 12/2022
2	HDL CholesterolIBA 01/2023 - 09/2018
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023 - 09/2018
2	HDL LipoproteinsIBA 01/2023 - 09/2018
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2017
2	TransferasesIBA 10/2020 - 01/2020
1	ProlactinIBA 02/2024
1	Growth Hormone (Somatotropin)IBA 02/2024
1	Antipsychotic Agents (Antipsychotics)IBA 01/2024
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023
1	Raloxifene Hydrochloride (Evista)FDA Link 08/2022
1	Vitamin D FDA LinkGeneric 08/2022
1	Cholecalciferol (Vitamin D3)FDA Link 08/2022
1	hydroxide ionIBA 08/2022
1	Ezetimibe (Zetia)FDA Link 09/2021
1	IodineIBA 04/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	CatecholaminesIBA 01/2021
1	JNK Mitogen-Activated Protein KinasesIBA 09/2020
1	PalmitatesIBA 09/2020
1	GinsenosidesIBA 09/2020
1	CC ChemokinesIBA 11/2019
1	AdipokinesIBA 11/2019
1	ResistinIBA 09/2018
1	C-Reactive ProteinIBA 09/2018
1	AdiponectinIBA 09/2018
1	Apolipoproteins B (ApoB)IBA 09/2018
1	Lipoproteins (Lipoprotein)IBA 09/2018
1	Serum AlbuminIBA 01/2017
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2017
1	MicronutrientsIBA 04/2016
1	BilirubinIBA 01/2016
1	Uric Acid (Urate)IBA 01/2016

Therapy/Procedure

3	Glycemic Control 05/2024 - 01/2021
3	Therapeutics 08/2022 - 09/2018
1	Artificial Pancreas 11/2019
1	Total Parenteral Nutrition 04/2016